{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:48:19Z","timestamp":1788058099616,"version":"build-2784847793"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12011-023-03893-9","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T22:01:56Z","timestamp":1696629716000},"page":"2954-2965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"202","author":[{"given":"Meire Ellen","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Siqueira","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Vicentin","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayara","family":"de Souza da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Ferreira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izonete Cristina","family":"Guiloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Irioda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Sirlene","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,7]]},"reference":[{"key":"3893_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/mmr.2019.10374","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma K (2019) Cholinesterase inhibitors as Alzheimer\u2019s therapeutics. Mol Med Rep 20:1479\u20131487. https:\/\/doi.org\/10.3892\/mmr.2019.10374","journal-title":"Mol Med Rep"},{"key":"3893_CR2","doi-asserted-by":"publisher","unstructured":"Oliveira CS, Piccoli BC, Nogara PA, Pereira ME, Carvalho KAT, Skalny AV, Tinkov AA, Aschner M, Rocha JBT (2021) Selenium neuroprotection in neurodegenerative disorders. In Handbook of Neurotoxicity, 2nd ed.; Kostrzewa RM, Ed.; Springer: Cham, Switzerland, 2021; Volume\u00a01, p.\u00a035. https:\/\/doi.org\/10.1007\/978-3-031-15080-7_238","DOI":"10.1007\/978-3-031-15080-7_238"},{"key":"3893_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","journal-title":"Lancet"},{"key":"3893_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","volume":"16","author":"M Fakhoury","year":"2018","unstructured":"Fakhoury M (2018) Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Curr Neuropharmacol 16:508\u2013518. https:\/\/doi.org\/10.2174\/1570159X15666170720095240","journal-title":"Curr Neuropharmacol"},{"key":"3893_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1586\/ern.11.57","volume":"11","author":"AS Buchman","year":"2011","unstructured":"Buchman AS, Bennett DA (2011) Loss of motor function in preclinical Alzheimer\u2019s disease. Expert Rev Neurother 11:665\u2013676. https:\/\/doi.org\/10.1586\/ern.11.57","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"3893_CR6","doi-asserted-by":"publisher","first-page":"e0238690","DOI":"10.1371\/journal.pone.0238690","volume":"15","author":"JK Kueper","year":"2020","unstructured":"Kueper JK, Lizotte DJ, Montero-Odasso M, Speechley M, Alzheimer\u2019s Disease Neuroimaging Initiative (2020) Cognition and motor function: the gait and cognition pooled index. PLoS ONE 15(9):e0238690. https:\/\/doi.org\/10.1371\/journal.pone.0238690","journal-title":"PLoS ONE"},{"key":"3893_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11920-015-0640-7","volume":"18","author":"AM Koenig","year":"2016","unstructured":"Koenig AM, Arnold SE, Streim JE (2016) Agitation and irritability in Alzheimer\u2019s Disease: evidenced-based treatments and the black-box warning. Curr Psychiatry Rep 18:3. https:\/\/doi.org\/10.1007\/s11920-015-0640-7","journal-title":"Curr Psychiatry Rep"},{"key":"3893_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/1570159x14666151223100011","volume":"14","author":"A Dominiak","year":"2016","unstructured":"Dominiak A, Wilkaniec A, Wroczy\u0144ski P, Adamczyk A (2016) Selenium in the therapy of neurological diseases. Where is it Going? Curr Neuropharmacol 14:282\u2013299. https:\/\/doi.org\/10.2174\/1570159x14666151223100011","journal-title":"Where is it Going? Curr Neuropharmacol"},{"key":"3893_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-14020-9","volume":"7","author":"S Pedrini","year":"2017","unstructured":"Pedrini S, Gupta VB, Hone E, Doecke J, O\u2019Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN, AIBL Research Group (2017) A blood-based biomarker panel indicates IL-10 and IL-12\/23p40 are jointly associated as predictors of \u03b2-amyloid load in an AD cohort. Sci Rep 7:1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-14020-9","journal-title":"Sci Rep"},{"key":"3893_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2147\/CIA.S27983","volume":"8","author":"BR Cardoso","year":"2013","unstructured":"Cardoso BR, Cominetti C, Cozzolino SM (2013) Importance and management of micronutrient deficiencies in patients with Alzheimer\u2019s disease. Clin Interv Aging 8:531\u2013542. https:\/\/doi.org\/10.2147\/CIA.S27983","journal-title":"Clin Interv Aging"},{"key":"3893_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/ijpvm.IJPVM_48_19","volume":"11","author":"A Mehri","year":"2020","unstructured":"Mehri A (2020) Trace elements in human nutrition (II) - an update. Int J Prev Med 11:2. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_48_19","journal-title":"Int J Prev Med"},{"key":"3893_CR12","doi-asserted-by":"publisher","unstructured":"Oliveira CS, Piccoli BC, Aschner M, Rocha JBT (2017) Chemical speciation of selenium and mercury as determinant of their neurotoxicity. In Neurotoxicity of Metals; Aschner M, Costa L, Eds.; Springer: Cham, Switzerland, Volume\u00a018, pp.\u00a053\u201383. https:\/\/doi.org\/10.1007\/978-3-319-60189-2_4","DOI":"10.1007\/978-3-319-60189-2_4"},{"key":"3893_CR13","doi-asserted-by":"publisher","unstructured":"Rocha JBT, Piccoli BC, Oliveira CS (2017) Biological and chemical interest in selenium: a brief historical account. Arkivoc 457\u2013491. https:\/\/doi.org\/10.24820\/ark.5550190.p009.784","DOI":"10.24820\/ark.5550190.p009.784"},{"key":"3893_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/1385272819666150810222632","volume":"20","author":"W Hassan","year":"2016","unstructured":"Hassan W, Oliveira CS, Noreen H, Kamdem JP, Nogueira CW, Rocha JBT (2016) Organoselenium compounds as potential neuroprotective therapeutic agents. Curr Org Chem 20:218\u2013231","journal-title":"Curr Org Chem"},{"key":"3893_CR15","doi-asserted-by":"publisher","unstructured":"Nogara PA, Oliveira CS, Rocha JBT (2020) Chemistry and pharmacology of synthetic organoselenium compounds. Organoselenium Chem., De Gruyter, Berlin, 305\u2013346. https:\/\/doi.org\/10.1515\/9783110625110-008","DOI":"10.1515\/9783110625110-008"},{"key":"3893_CR16","doi-asserted-by":"crossref","unstructured":"Rocha JB, Oliveira CS, Nogara PA (2017) Toxicology and anticancer activity of synthetic organoselenium compounds. Organoselenium Compounds in Biology and Medicine. Synthesis, Biological and Therapeutic Treatments, pp 342\u2013376","DOI":"10.1039\/9781788011907-00342"},{"key":"3893_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jtemb.2014.08.009","volume":"28","author":"BR Cardoso","year":"2014","unstructured":"Cardoso BR, Bandeira VS, Jacob-Filho W, Cozzolino SMF (2014) Selenium status in elderly: relation to cognitive decline. J Trace Elem Med Biol 28:422\u2013426. https:\/\/doi.org\/10.1016\/j.jtemb.2014.08.009","journal-title":"J Trace Elem Med Biol"},{"key":"3893_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00394-014-0829-2","volume":"55","author":"BR Cardoso","year":"2016","unstructured":"Cardoso BR, Apolin\u00e1rio D, Bandeira VS, Busse AL, Magaldi RM, Jacob-Filho W, Cozzolino SMF (2016) Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial. Eur J Nutr 55:107\u2013116. https:\/\/doi.org\/10.1007\/s00394-014-0829-2","journal-title":"Eur J Nutr"},{"key":"3893_CR19","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.3390\/nu14153205","volume":"14","author":"ME Pereira","year":"2022","unstructured":"Pereira ME, Souza JV, Galiciolli MEA, Sare F, Vieira GS, Kruk IL, Oliveira CS (2022) Effects of selenium supplementation in patients with mild cognitive impairment or Alzheimer\u2019s Disease: a systematic review and meta-analysis. Nutrients 14:3205. https:\/\/doi.org\/10.3390\/nu14153205","journal-title":"Nutrients"},{"key":"3893_CR20","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3390\/molecules26144230","volume":"26","author":"C Santi","year":"2021","unstructured":"Santi C, Scimmi C, Sancineto L (2021) Ebselen and Analogues: pharmacological properties and synthetic strategies for their preparation. Molecules 26:4230. https:\/\/doi.org\/10.3390\/molecules26144230","journal-title":"Molecules"},{"key":"3893_CR21","doi-asserted-by":"publisher","unstructured":"Nogara PA, Oliveira CS, Pereira ME, Bortoli M, Orian L, Aschner M, Rocha JBT (2022) Therapeutic applications of low-molecular-weight thiols and selenocompounds. In: Redox Chemistry and Biology of Thiols. Alvarez B, Comini MA, Salinas G, Trujillo M (Eds), Academic Press, Chap. 27, pp.\u00a0643\u2013677. https:\/\/doi.org\/10.1016\/B978-0-323-90219-9.00005-4","DOI":"10.1016\/B978-0-323-90219-9.00005-4"},{"key":"3893_CR22","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1523\/JNEUROSCI.3229-16.2017","volume":"37","author":"ZH Zhang","year":"2017","unstructured":"Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL (2017) Selenomethionine mitigates cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an Alzheimer\u2019s disease mouse model. J Neurosci 37:2449\u20132462. https:\/\/doi.org\/10.1523\/JNEUROSCI.3229-16.2017","journal-title":"J Neurosci"},{"key":"3893_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychires.2018.11.021","volume":"109","author":"F Martini","year":"2019","unstructured":"Martini F, Rosa SG, Klann IP, Fulco B, Carvalho FB, Rahmeier FL, Fernandes MC, Nogueira CW (2019) A multifunctional compound Ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer\u2019s disease. J Psychiatr Res 109:107\u2013117. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.11.021","journal-title":"J Psychiatr Res"},{"key":"3893_CR24","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1177\/1535370220949237","volume":"245","author":"SC Cogo","year":"2020","unstructured":"Cogo SC, Nascimento TGFC, Pinhatti FAB, Junior NF, Rodrigues BS, Cavalli LR, Elifio-Esposito S (2020) An overview of neuroblastoma cell lineage phenotypes and in vitro models. Exp Biol Med 245:1637\u20131647. https:\/\/doi.org\/10.1177\/1535370220949237","journal-title":"Exp Biol Med"},{"key":"3893_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9\u201321. https:\/\/doi.org\/10.1007\/978-1-62703-640-5_2","journal-title":"Methods Mol Biol"},{"key":"3893_CR26","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1007\/s12035-019-1605-3","volume":"56","author":"LM Medeiros","year":"2019","unstructured":"Medeiros LM, De Bastiani MA, Rico EP, Schonhofen P, Pfaffenseller B, Wollenhaupt-Aguiar B, Grun L, Barb\u00e9-Tuana F, Zimmer ER, Castro M, Parsons RB, Klamt F (2019) Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer\u2019s Disease studies. Mol Neurobiol 56:7355\u20137367. https:\/\/doi.org\/10.1007\/s12035-019-1605-3","journal-title":"Mol Neurobiol"},{"key":"3893_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","volume":"1337","author":"FM Lopes","year":"2010","unstructured":"Lopes FM, Schr\u00f6der R, da Frota ML Jr, Zanotto-Filho A, M\u00fcller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, Fernandes M, Klamt F (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85\u201394. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.102","journal-title":"Brain Res"},{"key":"3893_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-60761-999-4_22","volume":"698","author":"KA Trzaska","year":"2011","unstructured":"Trzaska KA, Rameshwar P (2011) Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol 698:295\u2013303. https:\/\/doi.org\/10.1007\/978-1-60761-999-4_22","journal-title":"Methods Mol Biol"},{"key":"3893_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"3893_CR30","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1016\/S0021-9258(20)81842-0","volume":"251","author":"JH Keen","year":"1976","unstructured":"Keen JH, Habig WH, Jakoby WB (1976) Mechanism for the several activities of the glutathione S-transferases. J Biol Chem 251:6183\u20136188","journal-title":"J Biol Chem"},{"key":"3893_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0302-4598(98)00072-5","volume":"45","author":"R Gao","year":"1998","unstructured":"Gao R, Yuan Z, Zhao Z, Gao X (1998) Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activity. Bioelect Bioenerg 45:41\u201345. https:\/\/doi.org\/10.1016\/S0302-4598(98)00072-5","journal-title":"Bioelect Bioenerg"},{"key":"3893_CR32","first-page":"158","volume":"70","author":"DE Paglia","year":"1967","unstructured":"Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158\u2013169","journal-title":"J Lab Clin Med"},{"key":"3893_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999","journal-title":"Anal Biochem"},{"key":"3893_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.vascn.2013.01.195","volume":"67","author":"LM Tetz","year":"2013","unstructured":"Tetz LM, Kamau PW, Cheng AA, Meeker JD, Loch-Caruso R (2013) Troubleshooting the dichlorofluorescein assay to avoid artifacts in measurement of toxicant-stimulated cellular production of reactive oxidant species. J Pharmacol Toxicol Methods 67:56\u201360. https:\/\/doi.org\/10.1016\/j.vascn.2013.01.195","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3893_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbrc.2004.05.075","volume":"319","author":"A J\u00e4ms\u00e4","year":"2004","unstructured":"J\u00e4ms\u00e4 A, Hasslund K, Cowburn RF, B\u00e4ckstr\u00f6m A, Vas\u00e4nge M (2004) The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer\u2019s disease-like tau phosphorylation. Biochem Biophys Res Commun 319:993\u20131000. https:\/\/doi.org\/10.1016\/j.bbrc.2004.05.075","journal-title":"Biochem Biophys Res Commun"},{"key":"3893_CR36","doi-asserted-by":"publisher","first-page":"53193","DOI":"10.3791\/53193","volume":"108","author":"MM Shipley","year":"2016","unstructured":"Shipley MM, Mangold CA, Szpara ML (2016) Differentiation of the SH-SY5Y human neuroblastoma cell line. J Vis Exp 108:53193. https:\/\/doi.org\/10.3791\/53193","journal-title":"J Vis Exp"},{"key":"3893_CR37","doi-asserted-by":"publisher","first-page":"118737","DOI":"10.1016\/j.bbamcr.2020.118737","volume":"1867","author":"L Hromadkova","year":"2020","unstructured":"Hromadkova L, Bezdekova D, Pala J, Schedin-Weiss S, Tjernberg LO, Hoschl C, Ovsepian SV (2020) Brain-derived neurotrophic factor (BDNF) promotes molecular polarization and differentiation of immature neuroblastoma cells into definitive neurons. Biochim Biophys Acta Mol Cell Res 1867:118737. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118737","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3893_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3233\/JAD-2010-091363","volume":"20","author":"L Agholme","year":"2010","unstructured":"Agholme L, Lindstr\u00f6m T, K\u00e5gedal K, Marcusson J, Hallbeck M (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimer\u2019s Dis 20:1069\u20131082. https:\/\/doi.org\/10.3233\/JAD-2010-091363","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3893_CR39","doi-asserted-by":"publisher","first-page":"851542","DOI":"10.3389\/fcell.2022.851542","volume":"10","author":"A Duly","year":"2022","unstructured":"Duly A, Kao F, Teo WS, Kavallaris M (2022) \u03b2III-tubulin gene regulation in health and disease. Front Cell Dev Biol 10:851542. https:\/\/doi.org\/10.3389\/fcell.2022.851542","journal-title":"Front Cell Dev Biol"},{"key":"3893_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4103\/1673-5374.153679","volume":"10","author":"PK Kamat","year":"2015","unstructured":"Kamat PK, Nath C (2015) Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer\u2019s disease. Neural Regen Res 10:365\u2013367. https:\/\/doi.org\/10.4103\/1673-5374.153679","journal-title":"Neural Regen Res"},{"key":"3893_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J, Mothes T, Kolahdouzan M, Eriksson O, Moslem M, Bergstr\u00f6m J, Ingelsson M, O\u2019Callaghan P, Healy LM, Falk A, Erlandsson A (2021) Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates. J Neuroinflammation 18:124. https:\/\/doi.org\/10.1186\/s12974-021-02158-3","journal-title":"J Neuroinflammation"},{"key":"3893_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2012.06.006","volume":"690","author":"PK Kamat","year":"2012","unstructured":"Kamat PK, Tota S, Rai S, Shukla R, Ali S, Najmi AK, Nath C (2012) Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats. Eur J Pharmacol 690:90\u201398. https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.006","journal-title":"Eur J Pharmacol"},{"key":"3893_CR43","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12640-019-0005-9","volume":"35","author":"A Kaushal","year":"2019","unstructured":"Kaushal A, Wani WY, Bal A, Gill KD, Kaur J (2019) Okadaic acid and hypoxia-induced dementia model of Alzheimer\u2019s type in rats. Neurotox Res 35:621\u2013634. https:\/\/doi.org\/10.1007\/s12640-019-0005-9","journal-title":"Neurotox Res"},{"issue":"9","key":"3893_CR44","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1523\/JNEUROSCI.3229-16.2017","volume":"37","author":"ZH Zhang","year":"2017","unstructured":"Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL (2017) Selenomethionine mitigates Cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an Alzheimer\u2019s Disease Mouse Model. J Neurosci 37(9):2449\u20132462. https:\/\/doi.org\/10.1523\/JNEUROSCI.3229-16.2017","journal-title":"J Neurosci"},{"key":"3893_CR45","doi-asserted-by":"publisher","unstructured":"Li X, Shi Q, Xu H, Xiong Y, Wang C, Le L, Lian J, Wu G, Peng F, Liu Q, Du X (2022) Ebselen Interferes with Alzheimer\u2019s Disease by Regulating Mitochondrial Function. Antioxidants (Basel) 11(7):1350. Published 2022 Jul 11. https:\/\/doi.org\/10.3390\/antiox11071350","DOI":"10.3390\/antiox11071350"},{"key":"3893_CR46","doi-asserted-by":"crossref","unstructured":"Nogara PA, Pereira ME, Orian L, Oliveira CS, Rocha JBT (2023) The Long Story of Ebselen: From About One Century of its Synthesis to Clinical Trials. In: Vito Lippolis; Claudio Santi; Eder J. Lenard\u00e3o; Antonio L. Braga. (Org.). The Long Story of Ebselen: From About One Century of its Synthesis to Clinical Trials. 1ed. p.\u00a0567\u2013591","DOI":"10.1039\/BK9781839167386-00567"},{"issue":"3","key":"3893_CR47","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s11033-020-05326-5","volume":"47","author":"IP Klann","year":"2020","unstructured":"Klann IP, Martini F, Rosa SG, Nogueira CW (2020) Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer\u2019s disease. Mol Biol Rep 47(3):2205\u20132215. https:\/\/doi.org\/10.1007\/s11033-020-05326-5","journal-title":"Mol Biol Rep"},{"key":"3893_CR48","doi-asserted-by":"publisher","first-page":"11705","DOI":"10.18632\/aging.202865","volume":"13","author":"W Zhu","year":"2021","unstructured":"Zhu W, Liu Y, Zhang W, Fan W, Wang S, Gu JH, Sun H, Liu F (2021) Selenomethionine protects hematopoietic stem\/progenitor cells against cobalt nanoparticles by stimulating antioxidant actions and DNA repair functions. Aging 13:11705\u201311726. https:\/\/doi.org\/10.18632\/aging.202865","journal-title":"Aging"},{"key":"3893_CR49","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/antiox8110546","volume":"8","author":"L Reyes","year":"2019","unstructured":"Reyes L, Bishop DP, Hawkins CL, Rayner BS (2019) Assessing the efficacy of Dietary Selenomethionine supplementation in the setting of Cardiac Ischemia\/Reperfusion Injury. Antioxid (Basel Switzerland) 8:546. https:\/\/doi.org\/10.3390\/antiox8110546","journal-title":"Antioxid (Basel Switzerland)"},{"key":"3893_CR50","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1042\/bj2670767","volume":"267","author":"EO Kajander","year":"1990","unstructured":"Kajander EO, Harvima RJ, Kauppinen L, Akerman KK, Martikainen H, Pajula RL, K\u00e4renlampi SO (1990) Effects of selenomethionine on cell growth and on S-adenosylmethionine metabolism in cultured malignant cells. Biochem J 267:767\u2013774. https:\/\/doi.org\/10.1042\/bj2670767","journal-title":"Biochem J"},{"key":"3893_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1667\/RR1708.1","volume":"172","author":"CO Wambi","year":"2009","unstructured":"Wambi CO, Sanzari JK, Sayers CM, Nuth M, Zhou Z, Davis J, Finnberg N, Lewis-Wambi JS, Ware JH, El-Deiry WS, Kennedy AR (2009) Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival. Radiat Res 172:175\u2013186. https:\/\/doi.org\/10.1667\/RR1708.1","journal-title":"Radiat Res"},{"key":"3893_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/ol.2013.1362","volume":"6","author":"M Nuth","year":"2013","unstructured":"Nuth M, Kennedy AR (2013) Mitigating effects of L-selenomethionine on low-dose iron ion radiation-induced changes in gene expression associated with cellular stress. Oncol Lett 6:35\u201342. https:\/\/doi.org\/10.3892\/ol.2013.1362","journal-title":"Oncol Lett"},{"key":"3893_CR53","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biomedicines11051346","volume":"11","author":"NS Costa","year":"2023","unstructured":"Costa NS, Lima LS, Oliveira FAM, Galiciolli MEA, Manzano MI, Garlet QI, Irioda AC, Oliveira CS (2023) Antiproliferative Effect of Inorganic and Organic Selenium Compounds in breast cell lines. Biomedicines 11:1346. https:\/\/doi.org\/10.3390\/biomedicines11051346","journal-title":"Biomedicines"},{"key":"3893_CR54","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1021\/tx0502544","volume":"19","author":"H Shi","year":"2006","unstructured":"Shi H, Liu S, Miyake M, Liu KJ (2006) Ebselen induced C6 glioma cell death in oxygen and glucose deprivation. Chem Res Toxicol 19:655\u2013660. https:\/\/doi.org\/10.1021\/tx0502544","journal-title":"Chem Res Toxicol"},{"key":"3893_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JAD-131805","volume":"41","author":"G Song","year":"2014","unstructured":"Song G, Zhang Z, Wen L, Chen C, Shi Q, Zhang Y, Ni J, Liu Q (2014) Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 41:85\u201399. https:\/\/doi.org\/10.3233\/JAD-131805","journal-title":"J Alzheimer\u2019s Dis"},{"key":"3893_CR56","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.bbagen.2009.03.026","volume":"1790","author":"RF Burk","year":"2009","unstructured":"Burk RF, Hill KE (2009) Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 1790:1441\u20131447. https:\/\/doi.org\/10.1016\/j.bbagen.2009.03.026","journal-title":"Biochim Biophys Acta"},{"key":"3893_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00775-017-1463-2","volume":"22","author":"Y Xie","year":"2017","unstructured":"Xie Y, Tan Y, Zheng Y, Du X, Liu Q (2017) Ebselen ameliorates \u03b2-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer\u2019s disease mice. J Biol Inorg Chem 22:851\u2013865. https:\/\/doi.org\/10.1007\/s00775-017-1463-2","journal-title":"J Biol Inorg Chem"},{"key":"3893_CR58","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/antiox11071350","volume":"11","author":"X Li","year":"2022","unstructured":"Li X, Shi Q, Xu H, Xiong Y, Wang C, Le L, Lian J, Wu G, Peng F, Liu Q, Du X (2022) Ebselen interferes with Alzheimer\u2019s disease by regulating mitochondrial function. Antioxidants 11:1350. https:\/\/doi.org\/10.3390\/antiox11071350","journal-title":"Antioxidants"},{"key":"3893_CR59","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, Khachaturian ZS (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132","journal-title":"Brain"},{"key":"3893_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000488580","volume":"25","author":"MA Farzi","year":"2019","unstructured":"Farzi MA, Sadigh-Eteghad S, Ebrahimi K, Talebi M (2019) Exercise improves recognition memory and acetylcholinesterase activity in the beta amyloid-induced rat model of Alzheimer\u2019s disease. Ann Neurosci 25:121\u2013125. https:\/\/doi.org\/10.1159\/000488580","journal-title":"Ann Neurosci"},{"key":"3893_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12031-013-0183-5","volume":"53","author":"ML Campanari","year":"2014","unstructured":"Campanari ML, Garc\u00eda-Ayll\u00f3n MS, Blazquez-Llorca L, Luk WK, Tsim K, S\u00e1ez-Valero J (2014) Acetylcholinesterase protein level is preserved in the Alzheimer\u2019s brain. J Mol Neurosci 53:446\u2013453. https:\/\/doi.org\/10.1007\/s12031-013-0183-5","journal-title":"J Mol Neurosci"},{"key":"3893_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnmol.2011.00022","volume":"4","author":"MS Garc\u00eda-Ayll\u00f3n","year":"2011","unstructured":"Garc\u00eda-Ayll\u00f3n MS, Small DH, Avila J, S\u00e1ez-Valero J (2011) Revisiting the role of acetylcholinesterase in Alzheimer\u2019s disease: cross-talk with P-tau and \u03b2-Amyloid. Front Mol Neurosci 4:22. https:\/\/doi.org\/10.3389\/fnmol.2011.00022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"3893_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0168-0102(02)00201-8","volume":"45","author":"JB Melo","year":"2003","unstructured":"Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45(1):117\u2013127. https:\/\/doi.org\/10.1016\/s0168-0102(02)00201-8","journal-title":"Neurosci Res"},{"key":"3893_CR64","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2174\/1381612820666141014124319","volume":"21","author":"F Martini","year":"2015","unstructured":"Martini F, Bruning CA, Soares SM, Nogueira CW, Zeni G (2015) Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition. Curr Pharm Des 21:920\u2013924. https:\/\/doi.org\/10.2174\/1381612820666141014124319","journal-title":"Curr Pharm Des"},{"issue":"10","key":"3893_CR65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/00207454.2013.879581","volume":"124","author":"M Aras","year":"2014","unstructured":"Aras M, Alta\u015f M, Meydan S, Nacar E, Karc\u0131o\u011flu M, Uluta\u015f KT, Serarslan Y (2014) Effects of ebselen on ischemia\/reperfusion injury in rat brain. Int J Neurosci 124(10):771\u2013776. https:\/\/doi.org\/10.3109\/00207454.2013.879581","journal-title":"Int J Neurosci"},{"key":"3893_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1006\/exnr.1997.6750","volume":"150","author":"DL Marcus","year":"1998","unstructured":"Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer\u2019s disease. Exp Neurol 150:40\u201344. https:\/\/doi.org\/10.1006\/exnr.1997.6750","journal-title":"Exp Neurol"},{"key":"3893_CR67","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.str.2005.06.007","volume":"13","author":"F Angelucci","year":"2005","unstructured":"Angelucci F, Baiocco P, Brunori M, Gourlay L, Morea V, Bellelli A (2005) Insights into the catalytic mechanism of glutathione S-transferase: the lesson from Schistosoma haematobium. Structure 13:1241\u20131246. https:\/\/doi.org\/10.1016\/j.str.2005.06.007","journal-title":"Structure"},{"key":"3893_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuint.2015.01.008","volume":"82","author":"AP Mazzetti","year":"2015","unstructured":"Mazzetti AP, Fiorile MC, Primavera A, Lo Bello M (2015) Glutathione transferases and neurodegenerative diseases. Neurochem Int 82:10\u201318. https:\/\/doi.org\/10.1016\/j.neuint.2015.01.008","journal-title":"Neurochem Int"},{"issue":"1","key":"3893_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2012.01.055","volume":"230","author":"FR Ianiski","year":"2012","unstructured":"Ianiski FR, Alves CB, Souza AC, Pinton S, Roman SS, Rhoden CR, Alves MP, Luchese C (2012) Protective effect of meloxicam-loaded nanocapsules against amyloid-\u03b2 peptide-induced damage in mice. Behav Brain Res 230(1):100\u2013107. https:\/\/doi.org\/10.1016\/j.bbr.2012.01.055","journal-title":"Behav Brain Res"},{"issue":"1\u20133","key":"3893_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s12011-014-0137-y","volume":"162","author":"EA Wilhelm","year":"2014","unstructured":"Wilhelm EA, Bortolatto CF, Jesse CR, Luchese C (2014) Ebselen protects against behavioral and biochemical toxicities induced by 3-nitropropionic acid in rats: correlations between motor coordination, reactive species levels, and succinate dehydrogenase activity. Biol Trace Elem Res 162(1\u20133):200\u2013210. https:\/\/doi.org\/10.1007\/s12011-014-0137-y","journal-title":"Biol Trace Elem Res"},{"key":"3893_CR71","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos E, Loscalzo J, Handy DE (2011) Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 15:1957\u20131997. https:\/\/doi.org\/10.1089\/ars.2010.3586","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"3893_CR72","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1177\/0748233713509429","volume":"32","author":"C Unsal","year":"2016","unstructured":"Unsal C, Oran M, Albayrak Y, Aktas C, Erboga M, Topcu B, Uygur R, Tulubas F, Yanartas O, Ates O, Ozen OA (2016) Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats. Toxicol Ind Health 32(4):730\u2013740. https:\/\/doi.org\/10.1177\/0748233713509429","journal-title":"Toxicol Ind Health"},{"key":"3893_CR73","doi-asserted-by":"publisher","first-page":"866","DOI":"10.17179\/excli2019-1749","volume":"18","author":"QI Garlet","year":"2019","unstructured":"Garlet QI, Haskel MVL, Pereira RP, da Silva WCFN, da Rocha JBT, Oliveira CS, Bonini JS (2019) Delta-aminolevulinate dehydratase and glutathione peroxidase activity in Alzheimer\u2019s disease: a case-control study. EXCLI J 18:866\u2013875. https:\/\/doi.org\/10.17179\/excli2019-1749","journal-title":"EXCLI J"},{"key":"3893_CR74","doi-asserted-by":"publisher","first-page":"e63283","DOI":"10.1371\/journal.pone.0063283","volume":"8","author":"P Martorell","year":"2013","unstructured":"Martorell P, Bataller E, Llopis S, Gonzalez N, Alvarez B, Mont\u00f3n F, Ortiz P, Ram\u00f3n D, Genov\u00e9s S (2013) A cocoa peptide protects Caenorhabditis elegans from oxidative stress and \u03b2-amyloid peptide toxicity. PLoS ONE 8:e63283. https:\/\/doi.org\/10.1371\/journal.pone.0063283","journal-title":"PLoS ONE"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-023-03893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-023-03893-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-023-03893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T02:23:57Z","timestamp":1714962237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12011-023-03893-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1007\/s12011-023-03893-9","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,7]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}